Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model

Collins, 2006, World kidney day: an idea whose time has come, Kidney Int, 69, 781, 10.1038/sj.ki.5000250 Eddy, 1996, Molecular insights into renal interstitial fibrosis, J Am Soc Nephrol, 7, 2495, 10.1681/ASN.V7122495 Vlassara, 2002, Diabetes and advanced glycation end products, J Intern Med, 251, 87, 10.1046/j.1365-2796.2002.00932.x Schleicher, 1997, Increased accumulation of the glycoxidation product N (epsilon)-(carboxymethyl) lysine in human tissues in diabetes and aging, J Clin Invest, 99, 457, 10.1172/JCI119180 Miyata, 2000, Relevance of oxidative and carbonyl stress to long-term uremic complications, Kidney Int, 76, S120, 10.1046/j.1523-1755.2000.07615.x Weiss, 2000, Mechanisms for the formation of glycoxidation products in end-stage renal disease, Kidney Int, 57, 2571, 10.1046/j.1523-1755.2000.00117.x Henle, 2003, AGEs in foods: do they play a role in uremia?, Kidney Int, 84, 145, 10.1046/j.1523-1755.63.s84.16.x Hofmann, 2002, Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse, Diabetes, 51, 2082, 10.2337/diabetes.51.7.2082 Uribarri, 2003, Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients, J Am Soc Nephrol, 14, 728, 10.1097/01.ASN.0000051593.41395.B9 Raj, 2000, Advanced glycation end products: a Nephrologist's perspective, Am J Kidney Dis, 35, 365, 10.1016/S0272-6386(00)70189-2 Hou, 2002, Beta 2-microglobulin amyloidosis: role of monocytes/macrophages, Curr Opin Nephrol Hypertens, 11, 417, 10.1097/00041552-200207000-00008 Hou, 2001, Beta(2)-microglobulin modified with advanced glycation end products delays monocyte apoptosis, Kidney Int, 59, 990, 10.1046/j.1523-1755.2001.059003990.x Vlassara, 1994, Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats, Proc Natl Acad Sci USA, 91, 11704, 10.1073/pnas.91.24.11704 Foerster, 2003, Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): studies on the urinary excretion of pyrraline, Biochem Soc Trans, 31, 1383, 10.1042/bst0311383 Faist, 2000, In vitro and in vivo studies on the metabolic transit of Nε-carboxymethyllysine, Czech J Food Sci, 18, 116 Hou, 2004, Enhanced expression of receptor for advanced glycation end products in chronic kidney disease, J Am Soc Nephrol, 15, 1889, 10.1097/01.ASN.0000131526.99506.F7 Šebeková, 2003, Effects of a diet rich in advanced glycation end products in the rat remnant kidney model, Am J Kidney Dis, 41, S48, 10.1053/ajkd.2003.50084 Hou, 1998, Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin, J Am Soc Nephrol, 9, 277, 10.1681/ASN.V92277 Fu, 1996, The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions, J Biol Chem, 271, 9982, 10.1074/jbc.271.17.9982 Cai, 2002, Oxidative stress-induced carbonyl compounds from common foods: novel mediators of cellular dysfunction, Mol Med, 8, 337, 10.1007/BF03402014 Singh, 2001, Advanced glycation end-products: a review, Diabetologia, 44, 129, 10.1007/s001250051591 Dittrich, 2006, Concentrations of Nepsilon-carboxymethyllysine in human breast milk, infant formulas, and urine of infants, J Agric Food Chem, 54, 6924, 10.1021/jf060905h Grunwald, 2006, Transepithelial flux of early and advanced glycation compounds across Caco-2 cell monolayers and their interaction with intestinal amino acid and peptide transport systems, Br J Nutr, 95, 1221, 10.1079/BJN20061793 He, 1999, Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration, Diabetes, 48, 1308, 10.2337/diabetes.48.6.1308 Howard, 2002, Sugar and cardiovascular disease: A statement for healthcare professionals from the Committee on Nutrition of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association, Circulation, 106, 523, 10.1161/01.CIR.0000019552.77778.04 Nath, 1992, Tubulointerstitial changes as a major determinant in the progression of renal damage, Am J Kidney Dis, 20, 1, 10.1016/S0272-6386(12)80312-X Cohen, 1997, Stenosis of the tubular neck: a possible mechanism for progressive renal failure, J Lab Clin Med, 129, 567, 10.1016/S0022-2143(97)90011-1 Huang, 2005, Effect of nitric oxide-cGMP-dependent protein kinase activation on advanced glycation end-product-induced proliferation in renal fibroblasts, J Am Soc Nephrol, 16, 2318, 10.1681/ASN.2005010030 Thomas, 2005, Interactions between renin angiotensin system and advanced glycation in the kidney, J Am Soc Nephrol, 16, 2976, 10.1681/ASN.2005010013 Segerer, 2000, Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies, J Am Soc Nephrol, 11, 152, 10.1681/ASN.V111152 Okuda, 1990, Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix, J Clin Invest, 86, 453, 10.1172/JCI114731 Koschinsky, 1997, Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy, Proc Natl Acad Sci USA, 94, 6474, 10.1073/pnas.94.12.6474 Peppa, 2003, Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice, Diabetes, 52, 2805, 10.2337/diabetes.52.11.2805 Wrobel, 1997, Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system, Clin Chem, 43, 1563, 10.1093/clinchem/43.9.1563 Lott, 1983, Evaluation of the Coomassie Brilliant Blue G-250 method for urinary protein, Clin Chem, 29, 1946, 10.1093/clinchem/29.11.1946 Levey, 1998, Clinical evaluation of renal function, 20 Raij, 1984, Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats, Kidney Int, 26, 137, 10.1038/ki.1984.147 Miyazaki, 2000, An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys, Nephrol Dial Transplant, 15, 1773, 10.1093/ndt/15.11.1773 Ots, 1998, Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation, J Am Soc Nephrol, 9, 224, 10.1681/ASN.V92224 Badid, 2000, Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney, Kidney Int, 58, 51, 10.1046/j.1523-1755.2000.00140.x Taal, 2001, Mechanisms underlying renoprotection during renin-angiotensin system blockade, Am J Physiol Renal Physiol, 280, F343, 10.1152/ajprenal.2001.280.2.F343 Taal, 2000, Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney, Kidney Int, 58, 1664, 10.1111/j.1523-1755.2000.00327.x Yagi, 1976, A simple fluorometric assay for lipoperoxide in blood plasma, Biochem Med, 15, 212, 10.1016/0006-2944(76)90049-1 Flohe, 1984, Assays of glutathione peroxidase, Methods Enzymol, 105, 114, 10.1016/S0076-6879(84)05015-1 Liu, 2006, Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation, Arterioscler Thromb Vasc Biol, 26, 1156, 10.1161/01.ATV.0000214960.85469.68